Cape ANN Savings Bank Decreases Stock Holdings in JPMorgan Chase & Co. (NYSE:JPM)

Cape ANN Savings Bank trimmed its position in JPMorgan Chase & Co. (NYSE:JPM) by 2.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 8,965 shares of the financial services provider’s stock after selling 180 shares during the period. JPMorgan Chase & Co. makes up 1.3% of Cape ANN Savings Bank’s holdings, making the stock its 20th biggest holding. Cape ANN Savings Bank’s holdings in JPMorgan Chase & Co. were worth $2,149,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Midwest Capital Advisors LLC purchased a new position in shares of JPMorgan Chase & Co. in the fourth quarter worth $43,000. Colonial River Investments LLC increased its position in JPMorgan Chase & Co. by 3.6% during the 4th quarter. Colonial River Investments LLC now owns 14,354 shares of the financial services provider’s stock valued at $3,441,000 after purchasing an additional 502 shares during the period. Birchcreek Wealth Management LLC increased its position in JPMorgan Chase & Co. by 3.5% during the 4th quarter. Birchcreek Wealth Management LLC now owns 7,153 shares of the financial services provider’s stock valued at $1,715,000 after purchasing an additional 241 shares during the period. Partners Wealth Management LLC purchased a new position in JPMorgan Chase & Co. during the 4th quarter valued at $971,000. Finally, World Equity Group Inc. increased its position in JPMorgan Chase & Co. by 99.7% during the 4th quarter. World Equity Group Inc. now owns 13,296 shares of the financial services provider’s stock valued at $3,187,000 after purchasing an additional 6,638 shares during the period. 71.55% of the stock is owned by hedge funds and other institutional investors.

JPMorgan Chase & Co. Stock Performance

Shares of JPMorgan Chase & Co. stock opened at $251.55 on Thursday. The stock has a market cap of $703.35 billion, a price-to-earnings ratio of 12.74, a PEG ratio of 2.83 and a beta of 1.12. The firm’s 50-day moving average is $259.33 and its 200 day moving average is $238.02. JPMorgan Chase & Co. has a 1 year low of $179.20 and a 1 year high of $280.25. The company has a debt-to-equity ratio of 1.24, a current ratio of 0.88 and a quick ratio of 0.89.

JPMorgan Chase & Co. (NYSE:JPM) last announced its quarterly earnings results on Wednesday, January 15th. The financial services provider reported $4.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.03 by $0.78. The company had revenue of $42.77 billion for the quarter, compared to analysts’ expectations of $41.90 billion. JPMorgan Chase & Co. had a net margin of 20.96% and a return on equity of 16.99%. JPMorgan Chase & Co.’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.04 EPS. Sell-side analysts anticipate that JPMorgan Chase & Co. will post 18.1 EPS for the current fiscal year.

JPMorgan Chase & Co. Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Monday, January 6th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date was Monday, January 6th. JPMorgan Chase & Co.’s payout ratio is 25.33%.

Analysts Set New Price Targets

A number of research analysts have issued reports on JPM shares. Barclays boosted their price objective on shares of JPMorgan Chase & Co. from $304.00 to $330.00 and gave the company an “overweight” rating in a research report on Thursday, January 16th. Wolfe Research raised shares of JPMorgan Chase & Co. from a “peer perform” rating to an “outperform” rating and set a $269.00 price objective on the stock in a research report on Friday, January 3rd. UBS Group boosted their price objective on shares of JPMorgan Chase & Co. from $276.00 to $287.00 and gave the company a “buy” rating in a research report on Thursday, January 16th. Truist Financial boosted their price objective on shares of JPMorgan Chase & Co. from $260.00 to $268.00 and gave the company a “hold” rating in a research report on Thursday, January 16th. Finally, Keefe, Bruyette & Woods boosted their target price on shares of JPMorgan Chase & Co. from $257.00 to $264.00 and gave the company a “market perform” rating in a report on Thursday, January 16th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $251.78.

Insider Buying and Selling at JPMorgan Chase & Co.

In other JPMorgan Chase & Co. news, insider Robin Leopold sold 1,250 shares of the company’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $270.09, for a total transaction of $337,612.50. Following the transaction, the insider now owns 50,377 shares in the company, valued at approximately $13,606,323.93. This represents a 2.42 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Stacey Friedman sold 3,303 shares of the company’s stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $253.94, for a total transaction of $838,763.82. Following the transaction, the general counsel now owns 47,620 shares in the company, valued at $12,092,622.80. This represents a 6.49 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 46,326 shares of company stock worth $12,448,445. Company insiders own 0.79% of the company’s stock.

About JPMorgan Chase & Co.

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.